Acetadote (acetylcysteine) Injection

MAY 01, 2006

Cumberland Pharmaceuticals (Nashville, Tenn) recently received FDA approval for revised labeling for Acetadote Injection. The product is used in an emergency room setting to prevent or lessen potential liver damage resulting from an overdose of acetaminophen, a common ingredient in many OTC painkillers. Acetadote, administered intravenously within 8 to 10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen, is indicated to prevent or lessen hepatic injury. The revised package insert includes a dosage guide for pediatric patients who weigh <40 kg. The loading dose (300 mg/kg) administration also has been extended to 60 minutes, making the total recommended treatment time 21 hours. Acetadote is available as a 20% solution in 30-mL (200 mg/mL) single-dose vials. For more information, visit www.acetadote.com, or call 877-484-2700.

SHARE THIS SHARE THIS
0
 

The Oncology Care Pharmacist in Health-System Pharmacy 
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.